WithdrawnNCT06878833
Safety study of Long-Acting Oral Risperidone in schizophrenia
This study has public registry information in Global. It is testing Long-Acting Oral Risperidone for schizophrenia.
SchizophreniaOtherFrom 18 Years to 65 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT06107803
Safety study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in schizophrenia
This study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine for schizophrenia.
SchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT01624649
A Study to Examine the Progression of Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment and to Analyze Associated Factors
This study is completed. It focuses on ADHD and currently lists study information in South Korea.
ADHDOtherFrom 6 Years to 15 Years
CompletedNCT00224510
A Study To Investigate The Antidepressant Effect Of Lamotrigine In people with Bipolarity Using Lithium
This study is completed. It focuses on bipolarity and currently lists study information in the Netherlands and Spain.
Bipolarity, DepressionOtherOver 18 Years
CompletedNCT06225115
Safety study of KYN-5356 in Schizophrenia
This study is completed in the United States. It is testing KYN-5356 for Schizophrenia.
SchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT04943796
A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
This study is completed in Canada, in the United Kingdom, in Switzerland, .... It focuses on ADHD.
ADHDOtherOver 18 Years
CompletedNCT01819818
A Study to Observe the Safety and Tolerability of Paliperidone Palmitate (Invega Sustenna) in Korean Schizophrenic Patients
This study is completed. It focuses on schizophrenia and currently lists study information in South Korea.
SchizophreniaOther
CompletedNCT06280235
A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine
This study is completed. It focuses on depression and currently lists study information in Belgium, Bulgaria, China, Czech Republic, Germany, Japan, and the United States.
DepressionOtherFrom 18 Years to 65 Years
CompletedNCT05278104
A Study to Test Different Ways to Measure the Effect of Atomoxetine on Impulsive Behavior in Young Adults With Attention Deficit Hyperactivity Disorder (ADHD)
This study is completed in Germany. It focuses on ADHD.
ADHDOtherFrom 18 Years to 45 Years
CompletedNCT03893825
A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia
This study is completed. It focuses on schizophrenia and currently lists study information in Bulgaria, Canada, France, Israel, and the United States.
SchizophreniaOtherFrom 13 Years to 65 Years
TerminatedNCT05211947
A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study
This study has public registry information in the United States, in Australia, in France, .... It focuses on schizophrenia.
SchizophreniaOtherFrom 18 Years to 51 Years
CompletedNCT00475735
A Study to Test the Safety and Efficacy of MK0249 in people with ADHD (0249-018)(COMPLETED)
This study is completed. It focuses on ADHD and currently lists study information in Global.
ADHDOtherFrom 18 Years to 55 Years